Impact of Thoratec notice limited , says Oppenheimer After Thoratec announced a worldwide urgent correction in order to update its labeling and training materials for the HeartMate II Pocket Controller, Oppenheimer says that the correction is not product related. The firm assumes the company does not need to take additional steps, and added that the notice is not expected to have a material financial impact on the company. The firm keeps a $45 price target and Outperform rating on the stock.
News For THOR From The Last 14 Days
Check below for free stories on THOR the last two weeks.